McGill and MUHC research teams part of an international effort to uncover how chronic inflammation causes cancer
McGill and MUHC research teams part of an international effort to uncover how chronic inflammation causes cancer
Several new medicines have been found to be more effective than traditional ones used to treat multidrug-resistant tuberculosis (MDR-TB), according to a new international collaborative study led by Dr. Dick Menzies, senior scientist at the Research Institute of the McGill University Health Centre (RI-MUHC) in Montreal. These findings precipitated a complete overhaul of worldwide TB treatment guidelines, with the results of this work published today in the British medical journal The Lancet.
According to a new study led by the Research Institute of the McGill University Health Centre (RI MUHC), older women who have been diagnosed with an irregular heartbeat are at higher risk of stroke than men.